MODELING THE COST-EFFECTIVENESS OF A NEW AND EXPENSIVE TREATMENT MODALITY IN LUNG CANCER: THE CASE OF PARTICLE THERAPY
Version 2 2024-06-04, 06:23Version 2 2024-06-04, 06:23
Version 1 2019-07-11, 14:00Version 1 2019-07-11, 14:00
conference contribution
posted on 2024-06-04, 06:23authored byJP Grutters, M Pijls-Johannesma, Ruysscher D De, AL Dekker, Anna PeetersAnna Peeters, JL Severens, P Lambin, MA Joore
MODELING THE COST-EFFECTIVENESS OF A NEW AND EXPENSIVE TREATMENT MODALITY IN LUNG CANCER: THE CASE OF PARTICLE THERAPY